National Technical Advisory Group on Immunisation
NTAGI analyzes data of Covid infections in India to decide on booster dose
During its last meeting, the NTAGI had made no final recommendation on additional COVID-19 vaccine doses
Decision to increase gap between Covishield doses based on scientific evidence: NTAGI
Dr Arora said that the earlier decision of four weeks was based upon the bridging trial data available then
Increase gap between two doses of Covishield to 12-16 weeks: Government panel
The panel also recommended that pregnant women may be offered the choice to take any vaccine
1 of 1